Compare LTC & NEOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LTC | NEOG |
|---|---|---|
| Founded | 1992 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 1994 | 1995 |
| Metric | LTC | NEOG |
|---|---|---|
| Price | $40.31 | $11.65 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $40.00 | $10.67 |
| AVG Volume (30 Days) | 510.7K | ★ 2.2M |
| Earning Date | 05-06-2026 | 04-09-2026 |
| Dividend Yield | ★ 5.96% | N/A |
| EPS Growth | 23.53 | ★ 99.20 |
| EPS | ★ 1.05 | N/A |
| Revenue | $262,854,000.00 | ★ $870,400,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $37.11 | ★ N/A |
| Revenue Growth | ★ 25.26 | N/A |
| 52 Week Low | $33.64 | $4.90 |
| 52 Week High | $43.00 | $12.85 |
| Indicator | LTC | NEOG |
|---|---|---|
| Relative Strength Index (RSI) | 54.49 | 62.89 |
| Support Level | $37.82 | $8.68 |
| Resistance Level | $40.80 | $12.85 |
| Average True Range (ATR) | 1.02 | 0.57 |
| MACD | -0.17 | 0.04 |
| Stochastic Oscillator | 56.16 | 67.24 |
LTC Properties Inc is a real estate investment trust. It invests in seniors housing and health care properties, mainly through ownership, sale-leasebacks, mortgage financing, joint ventures, construction financing, and structured finance solutions, including preferred equity, bridge, and mezzanine lending. The company's investment portfolio comprises several properties located throughout the USA, the majority of which are seniors housing and skilled nursing properties. The firm conducts and manages its business as two operating segments: Real Estate Investments, which generates maximum revenue, and SHOP.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.